R&D Grants for funding pharmaceutical research: Growing without ... Whilst equity investment is likely to be central to the funding strategy of many early-stage biotechs, grant funding can be a very useful alternative.
Events Partner Content 4th Annual PREDiCT Tumor Models San Francisco Serving the immuno-oncology scientific community
Partner Content Partner Content New collaboration will advance human-based drug evaluation Medicines Discovery Catapult and the Medical Research Council (MRC) Centre for Drug Safety
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.